Globe Life price target lowered to $147 from $152 at Piper Sandler

Piper Sandler analyst John Barnidge lowered the firm’s price target on Globe Life (GL) to $147 from $152 and keeps an Overweight rating on the shares following quarterly results. Life and health earnings were weak in Q1, which drove the miss, the firm says. Globe Life is working to come to some finality such that it can communicate the result of governmental agency inquiries that do not have much transparency with the process while acknowledging there has been some government distraction in the system the last several weeks, Piper adds.